Jan 16, 2026
When should clinicians switch patients with low TTR on warfarin to DOACs, and what are the risks for those with chronic kidney disease?
Patients on warfarin with persistently low time in therapeutic range (TTR <65%) should be assessed for a likely switch to a DOAC when modifiable causes of poor INR control have been addressed and the ...